Immunology/Autoimmune
- Ref-No.Technology
- 01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
- 01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 02-00330Mouse models for liver immunity and therapeutic vaccinations
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00399/32-00019
Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00417
Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 03-00454
ACE2 Inhibitors for therapy of inflammatory skin diseases and stimulation of pigmentation
- 03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
- 03-00539Sleeping Beauty transposase variants with increased safety due to reduced half-life
- 14-00097
Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
- 14-00097
Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
- 14-00173
Replacement of allergen challenge: Safely scoring prevalence & severity of allergies
- 15-00379
Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
- 15-00461
The physiological breast-milk proteins S100A8 and S100A9 promote an eubiotic gut state in infants
- 15-00523
Novel Diagnostic for Hepatitis
- 15-00611Engineered Immune Cells to Specifically Eliminate Undesired Immune Responses
- 15-00740
Maintenance of regulatory T cell phenotype by expression of IL-2 fusion protein
- 22-00009Quiescent B Cells for immune suppression in gene therapy
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
- 23-00069
NMDAR targeted CAAR-T cell therapy
- 32-00049
Recombinant uromodulin to prevent vascular calcification in chronic kidney disease
- 32-00124
TCR/CD3-specific CAR NK-92 cells for purification of TCR-modified T cell products
- 43-00013
CRISPR StAR: sgRNA expression vectors for reliable and reproducible in vivo screenings
- 44-00014
Unconventional T cell population as blood marker for Crohn's disease